Inactive Instrument

Analyst Reco. ATHENEXPAR

Equities

Ladenburg Thalmann Downgrades Athenex to Neutral From Buy	23-03-21	MT
Truist Securities Adjusts Athenex's Price Target to $3 from $6, Keeps Hold Rating	22-04-13	MT
SVB Leerink Adjusts Athenex's Price Target to $3 from $2, Keeps Market Perform Rating	22-03-17	MT
RBC Capital Adjusts Price Target on Athenex to $4 From $5, Maintains Outperform Rating, Assigns Speculative Risk Qualifier	22-03-17	MT
History shows stocks can weather rate hike cycle	22-03-16	RE
ATHENEX : RBC Cuts Price Target on Athenex to $5 From $8 Amid Discontinuation of Oraxol in Metastatic Breast Cancer; Outperform Kept	21-10-12	MT
ATHENEX : RBC Trims Price Target on Athenex to $8 From $9, Maintains Outperform Rating	21-08-06	MT
ATHENEX : Oppenheimer Downgrades Athenex to Perform from Outperform	21-03-02	MT
ATHENEX : RBC Capital Adjusts Price Target on Athenex to $9 From $33, Maintains Outperform Rating	21-03-02	MT
SVB Leerink Downgrades Athenex to Market Perform From Outperform, Adjusts Price Target to $5 From $22	21-03-02	MT
ATHENEX : SVB Leerink Downgrades Athenex to Market Perform From Outperform, Adjusts Price Target to $5 From $22	21-03-02	MT
ATHENEX : JPMorgan Downgrades Athenex to Neutral From Overweight, Adjusts Price Target to $7 From $30	21-03-02	MT
ATHENEX : Truist Downgrades Athenex to Hold From Buy, Sets $6 Price Target	21-03-02	MT
ATHENEX : Needham Adjusts Athenex' Price Target to $27 from $30, Maintains Buy Rating	20-11-05	MT

No results for this search